Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Signed Consent	STARTED	Vyvanse	38
Signed Consent	STARTED	Placebo	37
Signed Consent	COMPLETED	Vyvanse	35
Signed Consent	COMPLETED	Placebo	34
Signed Consent	NOT COMPLETED	Vyvanse	3
Signed Consent	NOT COMPLETED	Placebo	3
Received Study Drug/Placebo	STARTED	Vyvanse	35
Received Study Drug/Placebo	STARTED	Placebo	34
Received Study Drug/Placebo	COMPLETED	Vyvanse	31
Received Study Drug/Placebo	COMPLETED	Placebo	30
Received Study Drug/Placebo	NOT COMPLETED	Vyvanse	4
Received Study Drug/Placebo	NOT COMPLETED	Placebo	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00801229/flow